Eye Journal

Chloroquine retinopathy: pattern of presentation in Ibadan, Sub-Sahara Africa Eye 30, 64 (January 2016). doi:10.1038/eye.2015.185 Authors: T S Oluleye, Y Babalola & M Ijaduola

• 7 January 2016

The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease Eye 30, 68 (January 2016). doi:10.1038/eye.2015.170 Authors: J Taylor, L J Scott, C A Rogers, A Muldrew, D O’Reilly, S Wordsworth, N Mills, R Hogg, M Violato,

• 7 January 2016

Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab Eye 30, 79 (January 2016). doi:10.1038/eye.2015.175 Authors: T D Papakostas, L Lim, T van Zyl, J B Miller, B S Modjtahedi, C M Andreoli, D Wu, L H Young, I K Kim, D G Vavvas,

• 7 January 2016

Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children Eye 30, 85 (January 2016). doi:10.1038/eye.2015.189 Authors: S Okumuş, V Öner, C Durucu, E Coşkun, Ü Aksoy, E Durucu, L Şahin & I Erbağcı

• 7 January 2016

Meeting the UK driving vision standards with reduced contrast sensitivity Eye 30, 89 (January 2016). doi:10.1038/eye.2015.188 Authors: S Rae, K Latham & M F Katsou

• 7 January 2016